Contact Us
Office Phone
886-2-2771-3403
E-Mail
jihshun@wpto.com.tw
TOP
Quick application

Contact us

Home
Israel's BrainStorm gets U.S. patent for stem cell technology
2014-04-10
 

IP News

Home > IP News

Israel's BrainStorm gets U.S. patent for stem cell technology

2014-04-10

srael-based BrainStorm Cell Therapeutics said on Monday the U.S. Patent and Trademark Office has granted the company a key patent for its autologous stem cell technology.

The patent covers BrainStorm's stem cells induced to secrete elevated levels of neurotrophic factors for the treatment of neurodegenerative diseases.

Pending approval from the U.S. Food & Drug Administration, the company is preparing for its upcoming mid-stage Phase II trial in the United States with its NurOwn adult stem cell therapy.

BrainStorm is developing NurOwn for the treatment of amyotrophic lateral sclerosis (ALS), also known as Lou Gehrig's Disease, a progressive neurodegenerative disease that affects nerve cells in the brain and spinal cord.

Separately, the company said it has signed a definitive agreement with Massachusetts General Hospital in Boston to conduct a Phase II clinical trial of NurOwn in ALS, pending FDA approval. The other two clinical sites slated for the trial are the University of Massachusetts Memorial Hospital and Mayo Clinic.

 

To continue reading, click here.

http://news.yahoo.com/israels-brainstorm-gets-u-patent-stem-cell-technology-040728952--finance.html;_ylt=AwrSyCPbEkJTGHQAcBHQtDMD

 

(These latest Intellectual Property (IP) news and events presented here, are prepared and compiled by us, the World Patent & Trademark Law Office (WPTO),for your reference and information)